Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis

FASEB Journal

Volumn 29, Issue 4, 2015, Pages 1247-1257

  Gawish, Riem ^a,b   Martins, Rui ^a,b   Böhm, Benedikta ^a,b   Wimberger, Terje ^a,b   Sharif, Omar ^a,b   Lakovits, Karin ^b   Schmidt, Mariane ^c   Knapp, Sylvia ^a,b  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Inflammation; Macrophages; Negative regulator; Peritonitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOOXYGENASE 2; GLYCOPEPTIDASE; GLYCOSIDASES ENDOGLYCOSIDASE H; I KAPPA B ALPHA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; TLR4 PROTEIN, MOUSE; TREM2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOTOXEMIA; ESCHERICHIA COLI INFECTION; FEMALE; GOLGI COMPLEX; GRAM NEGATIVE SEPSIS; HYPOTHERMIA; IMMUNE RESPONSE; INNATE IMMUNITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PERITONEUM CELL; PERITONEUM EXUDATE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BACTERIAL LOAD; C57BL MOUSE; DEFICIENCY; ESCHERICHIA COLI INFECTIONS; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PERITONITIS; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MUS; NEGIBACTERIA;

ANIMALS; BACTERIAL LOAD; DOWN-REGULATION; ENDOTOXEMIA; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONITIS; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 84931374582     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-260067     Document Type: Article

References (64)

1. Holzheimer, R. G., Muhrer, K. H., L'Allemand, N., Schmidt, T., and Henneking, K. (1991) Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 19, 447-452
2. Russell, J. A. (2006) Management of sepsis. N. Engl. J. Med. 355, 1699-1713
3. Janeway, C. A., Jr., and Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216
4. Medzhitov, R., and Janeway, C. A., Jr. (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296, 298-300
5. Van 't Veer, C., van den Pangaart, P. S., Kruijswijk, D., Florquin, S., de Vos, A. F., and van der Poll, T. (2011) Delineation of the role of Toll-like receptor signaling during peritonitis by a gradually growing pathogenic Escherichia coli. J. Biol. Chem. 286, 36603-36618
6. Van Westerloo, D. J., Weijer, S., Bruno, M. J., de Vos, A. F., Van't Veer, C., and van der Poll, T. (2005) Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis. Crit. Care Med. 33, 1036-1043
7. Riedemann, N. C., Guo, R. F., and Ward, P. A. (2003) The enigma of sepsis. J. Clin. Invest. 112, 460-467
8. Aziz, M., Jacob, A., Yang, W. L., Matsuda, A., and Wang, P. (2013) Current trends in inflammatory and immunomodulatory mediators in sepsis. J. Leukoc. Biol. 93, 329-342
9. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., and Akira, S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752
10. Henson, P. M. (2005) Dampening inflammation. Nat. Immunol. 6, 1179-1181
11. Sharif, O., and Knapp, S. (2008) From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213, 701-713
12. Ford, J. W., and McVicar, D. W. (2009) TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 21, 38-46
13. Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., and Colonna, M. (2006) Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520-3524
14. Hamerman, J. A., and Lanier, L. L. (2006) Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006, re1
15. Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., and Lanier, L. L. (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055
16. Ito, H., and Hamerman, J. A. (2012) TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur. J. Immunol. 42, 176-185
17. Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., and Seaman, W. E. (2003) Pattern recognition by TREM-2: binding of anionic ligands. J. Immunol. 171, 594-599
18. N'Diaye, E. N., Branda, C. S., Branda, S. S., Nevarez, L., Colonna, M., Lowell, C., Hamerman, J. A., and Seaman, W. E. (2009) TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J. Cell Biol. 184, 215-223
19. Chen, Q., Zhang, K., Jin, Y., Zhu, T., Cheng, B., Shu, Q., and Fang, X. (2013) Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. Am. J. Respir. Crit. Care Med. 188, 201-212
20. Klesney-Tait, J., Turnbull, I. R., and Colonna, M. (2006) The TREM receptor family and signal integration. Nat. Immunol. 7, 1266-1273
21. Lanier, L. L. (2009) DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227, 150-160
22. Barrow, A. D., and Trowsdale, J. (2006) You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur. J. Immunol. 36, 1646-1653
23. Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., and Humphrey, M. B. (2010) TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 3, ra38
24. Peng, Q., Long, C. L., Malhotra, S., and Humphrey, M. B. (2013) A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages. Sci. Signal. 6, ra72
25. Nasu, T., Tsukahara, Y., and Terayama, K. (1973) A lipid metabolic disease-"membranous lipodystrophy"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol. Jpn. 23, 539-558
26. Bianchin, M. M., Capella, H. M., Chaves, D. L., Steindel, M., Grisard, E. C., Ganev, G. G., da Silva Júnior, J. P., Neto Evaldo, S., Poffo, M. A., Walz, R., Carlotti Júnior, C. G., and Sakamoto, A. C. (2004) Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy - PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell. Mol. Neurobiol. 24, 1-24
27. Hakola, H. P., Järvi, O. H., and Sourander, P. (1970) Osteodysplasia polycystica hereditaria combined with sclerosing leucoencephalopathy, a new entity of the dementia praesenilis group. Acta Neurol. Scand. 46(Suppl 43), 79
28. Cella, M., Buonsanti, C., Strader, C., Kondo, T., Salmaggi, A., and Colonna, M. (2003) Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198, 645-651
29. Colonna, M., Turnbull, I., and Klesney-Tait, J. (2007) The enigmatic function of TREM-2 in osteoclastogenesis. Adv. Exp. Med. Biol. 602, 97-105
30. Park-Min, K. H., Ji, J. D., Antoniv, T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M., and Ivashkiv, L. B. (2009) IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J. Immunol. 183, 2444-2455
31. Paloneva, J., Mandelin, J., Kiialainen, A., Bohling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., and Peltonen, L. (2003) DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J. Exp. Med. 198, 669-675
32. Takahashi, K., Rochford, C. D., and Neumann, H. (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647-657
33. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J.; Alzheimer Genetic Analysis Group. (2013) TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127
34. Arts, R. J., Joosten, L. A., van der Meer, J. W., and Netea, M. G. (2013) TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J. Leukoc. Biol. 93, 209-215
35. Bouchon, A., Facchetti, F., Weigand, M. A., and Colonna, M. (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103-1107
36. Knapp, S., Gibot, S., de Vos, A., Versteeg, H. H., Colonna, M., and van der Poll, T. (2004) Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J. Immunol. 173, 7131-7134
37. Gibot, S., Kolopp-Sarda, M. N., Béné, M. C., Bollaert, P. E., Lozniewski, A., Mory, F., Levy, B., and Faure, G. C. (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 200, 1419-1426
38. Sun, M., Zhu, M., Chen, K., Nie, X., Deng, Q., Hazlett, L. D., Wu, Y., Li, M., Wu, M., and Huang, X. (2013) TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway. Invest. Ophthalmol. Vis. Sci. 54, 3451-3462
39. Sharif, O., Gawish, R., Warszawska, J. M., Martins, R., Lakovits, K., Hladik, A., Doninger, B., Brunner, J., Korosec, A., Schwarzenbacher, R. E., Berg, T., Kralovics, R., Colinge, J., Mesteri, I., Gilfillan, S., Salmaggi, A., Verschoor, A., Colonna, M., and Knapp, S. (2014) The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia. PLoS Pathog. 10, e1004167
40. Knapp, S., de Vos, A. F., Florquin, S., Golenbock, D. T., and van der Poll, T. (2003) Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect. Immun. 71, 6747-6753
41. Knapp, S., Matt, U., Leitinger, N., and van der Poll, T. (2007) Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J. Immunol. 178, 993-1001
42. Matt, U., Sharif, O., Martins, R., Furtner, T., Langeberg, L., Gawish, R., Elbau, I., Zivkovic, A., Lakovits, K., Oskolkova, O., Doninger, B., Vychytil, A., Perkmann, T., Schabbauer, G., Binder, C. J., Bochkov, V. N., Scott, J. D., and Knapp, S. (2013) WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs. J. Clin. Invest. 123, 3014-3024
43. Sharif, O., Matt, U., Saluzzo, S., Lakovits, K., Haslinger, I., Furtner, T., Doninger, B., and Knapp, S. (2013) The scavenger receptor CD36 downmodulates the early inflammatory response while enhancing bacterial phagocytosis during pneumococcal pneumonia. J. Immunol. 190, 5640-5648
44. Zhang, X., Goncalves, R., and Mosser, D. M. (2008) The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14, Unit 14.1
45. Bürckstümmer, T., Bennett, K. L., Preradovic, A., Schütze, G., Hantschel, O., Superti-Furga, G., and Bauch, A. (2006) An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat. Methods 3, 1013-1019
46. Lagler, H., Sharif, O., Haslinger, I., Matt, U., Stich, K., Furtner, T., Doninger, B., Schmid, K., Gattringer, R., de Vos, A. F., and Knapp, S. (2009) TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J. Immunol. 183, 2027-2036
47. Liew, F. Y., Xu, D., Brint, E. K., and O'Neill, L. A. (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458
48. Broche, F., and Tellado, J. M. (2001) Defense mechanisms of the peritoneal cavity. Curr. Opin. Crit. Care 7, 105-116
49. Holmes, C. J. (1996) Peritoneal host defense mechanisms. Perit. Dial. Int. 16(Suppl 1), S124-S125
50. Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., and Walter, J. (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and g-secretasedependent intramembranous cleavage. J. Biol. Chem. 288, 33027-33036
51. Hoogerwerf, J. J., de Vos, A. F., van't Veer, C., Bresser, P., de Boer, A., Tanck, M. W., Draing, C., van der Zee, J. S., and van der Poll, T. (2010) Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. Am. J. Respir. Cell Mol. Biol. 42, 349-356
52. Kondo, T., Kawai, T., and Akira, S. (2012) Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449-458
53. Anwar, M. A., Basith, S., and Choi, S. (2013) Negative regulatory approaches to the attenuation of Toll-like receptor signaling. Exp. Mol. Med. 45, e11
54. Bouchon, A., Hernández-Munain, C., Cella, M., and Colonna, M. (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194, 1111-1122
55. Paulson, J. C., and Colley, K. J. (1989) Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem. 264, 17615-17618
56. Parekh, R. B., Dwek, R. A., Thomas, J. R., Opdenakker, G., Rademacher, T. W., Wittwer, A. J., Howard, S. C., Nelson, R., Siegel, N. R., and Jennings, M. G. (1989) Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator. Biochemistry 28, 7644-7662
57. Zeck, A., Pohlentz, G., Schlothauer, T., Peter-Katalinić, J., and Regula, J. T. (2011) Cell type-specific and site directed N-glycosylation pattern of FcgRIIIa. J. Proteome Res. 10, 3031-3039
58. Chen, L. C., Laskin, J. D., Gordon, M. K., and Laskin, D. L. (2008) Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp. Mol. Pathol. 84, 145-155
59. Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R. C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., McNally, E., Pickart, C., and Ma, A. (2004) The ubiquitinmodifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060
60. Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Jr., Medzhitov, R., and Flavell, R. A. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202
61. Coornaert, B., Carpentier, I., and Beyaert, R. (2009) A20: central gatekeeper in inflammation and immunity. J. Biol. Chem. 284, 8217-8221
62. Vereecke, L., Beyaert, R., and van Loo, G. (2009) The ubiquitinediting enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30, 383-391
63. Arvelo, M. B., Cooper, J. T., Longo, C., Daniel, S., Grey, S. T., Mahiou, J., Czismadia, E., Abu-Jawdeh, G., and Ferran, C. (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35, 535-543
64. Correale, C., Genua, M., Vetrano, S., Mazzini, E., Martinoli, C., Spinelli, A., Arena, V., Peyrin-Biroulet, L., Caprioli, F., Passini, N., Panina-Bordignon, P., Repici, A., Malesci, A., Rutella, S., Rescigno, M., and Danese, S. (2013) Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response. Gastroenterology 144, 346-356. e343